PAVmed Inc

Research PAVmed Inc (PAVM) on Bullrun: market cap USD 33.07M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 33.07M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 71.00K-USD 3.77M-USD 5.24M-207.0%-5.63USD 1.54MUSD 13.35MUSD 33.97M
FY2024USD 3.00MUSD 31.97M-USD 33.61M-61.6%14.9USD 1.19MUSD 31.86M-USD 2.50M
FY2023USD 2.45M-USD 66.27M-USD 52.28M-161.8%-9.16USD 19.64MUSD 48.73M-USD 53.83M
FY2022USD 377.00K-USD 88.98M-USD 72.53M-858.6%-15.03USD 39.74MUSD 32.63M-USD 9.68M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 33.07Mn/an/an/a
20252025-12-31USD 6.11Mn/an/an/a
20242024-12-31USD 7.03M15.3n/an/a
20232023-12-29USD 33.17Mn/an/an/a
20222022-12-30USD 44.52Mn/an/an/a
20212021-12-31USD 212.43Mn/an/an/a

About PAVmed Inc

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is PAVmed Inc's market cap?

PAVmed Inc's market capitalization is USD 33.07M.

What does PAVmed Inc do?

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States.